Medical Device News Magazine

Deactivating COVID-19 on Footwear

New Study Show UVC Technology Deactivates COVID-19 on Footwear

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Researchers have proven a device using ultraviolet light technology can neutralize the COVID-19 virus and other infectious diseases on the soles of shoes by more than 99.5 percent, according to a new study.

The device, called HealthySole® PLUS, is being introduced in hospitals and other settings where infection control is urgent. A home version of the device (HealthySole® HOME) is also available.

“The device deactivated coronavirus markers by over 99.5 percent versus the control across three separate tests,” according to the report as published by CREM Co, an internationally recognized infectious disease research and testing organization based near Toronto, Canada.

As hospitals seek ways to reduce COVID-19 infections, a recent Center for Disease Control (CDC) report points out that the virus is spread through floors and foot traffic, and not just by person-to-person contact.

“As people walk, they not only collect and spread pathogens on the soles of their shoes, but also aerosolize the virus, essentially kicking it back up in the air,” said HealthySole CEO Nelson Patterson. “The HealthySole device helps ensure pathogens aren’t tracked from patient rooms or wards to other locations. Preventing pathogen spread is critical for hospitals and other facilities, such as police stations with close quarters and high foot traffic, too.”

CDC Cites Wuhan Study on COVID-19 Spread in Hospitals

Research published April 10 by the CDC found that floors and shoe soles had the highest concentrations of COVID-19 in samples taken at a hospital facility in Wuhan, China. It also found the virus was being tracked well beyond patient rooms to other parts of the hospital, including into non-patient care areas such as hospital pharmacies where sampling indicated a 100 percent COVID-19 presence.

The study strongly recommended that “persons disinfect shoe soles before walking out of wards containing COVID-19 patients.”

While hospitals often scrub floors daily with a variety of cleaning agents, these steps provide only a temporary solution. As soon as someone walks on the cleaned floors with infected shoes, floors are rapidly re-contaminated, sometimes in as little as 30 minutes.

Prior research on one of the most difficult to control hospital pathogens, C. difficile, conducted at Children’s Hospital at Erlanger by the University of Tennessee College of Medicine at Chattanooga found UVC light exposure to shoe soles to be statistically beneficial with an overall average decrease of 28 percent for the number of positive swabs per room.

“These studies clearly show that infection prevention must move beyond the traditional single-minded focus on hand washing and reliance on personal protective equipment (PPEs),” Patterson said. “We have to look at our shoe soles – where we’ve been and where we’re going. Fortunately, UVC technology is offering a solution.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”